Banque Pictet & Cie Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$153M |
| 2 |
Visa
V
|
+$56.4M |
| 3 |
iShares MSCI Japan ETF
EWJ
|
+$29.9M |
| 4 |
Cigna
CI
|
+$20.5M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$238M |
| 2 |
Tesla
TSLA
|
+$121M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$14.7M |
| 4 |
Wolfspeed
WOLF
|
+$11.7M |
| 5 |
Advanced Micro Devices
AMD
|
+$11.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 22.97% |
| 2 | Healthcare | 17.61% |
| 3 | Consumer Staples | 11.48% |
| 4 | Technology | 11.09% |
| 5 | Communication Services | 10.02% |
Similar funds
Banque Pictet & Cie's Q2 2023 Portfolio in Review
As of Q2 2023, Banque Pictet & Cie held 631 positions worth $11.4B, up 11% from $10.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Banque Pictet & Cie deployed $423M of net new capital in Q2 2023, opening 66 new positions and adding to 163 existing holdings. Its largest new stake was MoonLake Immunotherapeutics: 640,000 shares worth $32.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $238M trimmed.
- Banque Pictet & Cie's largest Q2 2023 buy was MoonLake Immunotherapeutics: 640,000 shares worth $32.6M.
- Banque Pictet & Cie added most to Estee Lauder in Q2 2023, an estimated $153M increase.
- Banque Pictet & Cie's biggest Q2 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $238M.
- Banque Pictet & Cie fully exited Wolfspeed in Q2 2023, selling an estimated $11.7M.
- Banque Pictet & Cie's ten largest holdings make up 45% of its $11.4B portfolio in Q2 2023.
- Banque Pictet & Cie opened 66 new positions and closed 151 in Q2 2023.
- Banque Pictet & Cie's portfolio value rose 11% quarter-over-quarter to $11.4B.
Based on Banque Pictet & Cie's 13F filing for Q2 2023, filed 4 Aug 2023.